As of 2026-09-19, the Relative Valuation of Terns Pharmaceuticals Inc (TERN) is (21.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 52.95 USD, the upside of Terns Pharmaceuticals Inc based on Relative Valuation is -141.3%.
The range of the Relative Valuation is (17.24) - (18.09) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.7x - 34.2x | 30.9x |
| Forward P/E multiples | 17.8x - 21.7x | 21.6x |
| Fair Price | (17.24) - (18.09) | (21.86) |
| Upside | -132.6% - -134.2% | -141.3% |
| Date | P/E |